Stock 6118 AUSTAR LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Austar Lifesciences Limited

Equities

6118

KYG0632L1023

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.82 HKD -7.87% Intraday chart for Austar Lifesciences Limited -18.00% -47.44%
Mar. 26 Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 22 Austar Lifesciences to Swing to Loss; Shares Drop MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Austar Lifesciences to Swing to Loss; Shares Drop
MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
Austar Lifesciences Hires New Auditor
MT
Austar Lifesciences Swings to Loss in H1
MT
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China
CI
Austar Lifesciences Expects Higher Loss in H1
MT
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023
CI
Austar Lifesciences Warns of H1 Loss
MT
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023
CI
Austar Lifesciences Announces 2022 Annual Results
AQ
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan
MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022
CI
Austar Lifesciences Limited Announces Executive Changes
CI
Austar Lifesciences Limited(SEHK:6118) dropped from S&P Global BMI Index
CI
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Austar Lifesciences Forecasts H1 Profit Fall to $6.4 Million
MT
Austar Lifesciences Limited acquired an unknown minority interest in Noozle Fluid Technology Co., Ltd..
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6118 Stock
  4. News Austar Lifesciences Limited